Researchmoz
added Most up-to-date research on "Chronic Coronary Artery
Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2015"
to its huge collection of research reports.
Global
Markets Directs, Chronic Coronary Artery Disease (CAD) (Ischemic
Heart Disease) - Pipeline Review, H2 2015, provides an overview of
the Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease)s
therapeutic pipeline.
To
Get Sample Copy of Report visit @
http://www.researchmoz.us/enquiry.php?type=S&repid=359924
This
report provides comprehensive information on the therapeutic
development for Chronic Coronary Artery Disease (CAD) (Ischemic Heart
Disease), complete with comparative analysis at various stages,
therapeutics assessment by drug target, mechanism of action (MoA),
route of administration (RoA) and molecule type, along with latest
updates, and featured news and press releases. It also reviews key
players involved in the therapeutic development for Chronic Coronary
Artery Disease (CAD) (Ischemic Heart Disease) and special features on
late-stage and discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, Company/University websites,
SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources,
put together by Global Markets Directs team. Drug profiles/records
featured in the report undergoes periodic updation following a
stringent set of processes that ensures that all the profiles are
updated with the latest set of information. Additionally, processes
including live news & deals tracking, browser based alert-box and
clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
The
report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class products.
Browse
Detail Report With TOC @
http://www.researchmoz.us/chronic-coronary-artery-disease-cad-ischemic-heart-disease-pipeline-review-h2-2015-report.html
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease)
-
The report reviews key pipeline products under drug profile section
which includes, product description, MoA and R&D brief, licensing
and collaboration details & other developmental activities
-
The report reviews key players involved in the therapeutics
development for Chronic Coronary Artery Disease (CAD) (Ischemic Heart
Disease) and enlists all their major and minor projects
-
The report summarizes all the dormant and discontinued pipeline
projects
-
A review of the Chronic Coronary Artery Disease (CAD) (Ischemic Heart
Disease) products under development by companies and
universities/research institutes based on information derived from
company and industry-specific sources
-
Pipeline products coverage based on various stages of development
ranging from pre-registration till discovery and undisclosed stages
-
A detailed assessment of monotherapy and combination therapy pipeline
projects
-
Coverage of the Chronic Coronary Artery Disease (CAD) (Ischemic Heart
Disease) pipeline on the basis of target, MoA, route of
administration and molecule type
-
Latest news and deals relating related to pipeline products
Reasons
to buy
-
Provides strategically significant competitor information, analysis,
and insights to formulate effective R&D development strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive
advantage
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Identify and understand important and diverse types of therapeutics
under development for Chronic Coronary Artery Disease (CAD) (Ischemic
Heart Disease)
-
Plan mergers and acquisitions effectively by identifying key players
of the most promising pipeline
-
Devise corrective measures for pipeline projects by understanding
Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease)
pipeline depth and focus of Indication therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline
Browse
All Reports in Pharmaceutical Category @
http://www.researchmoz.us/pharmaceutical-market-reports-38.html
Table
of Contents
Table
of Contents 2
List
of Tables 4
List
of Figures 4
Introduction
5
Global
Markets Direct Report Coverage 5
Chronic
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Overview 6
Therapeutics
Development 7
Pipeline
Products for Chronic Coronary Artery Disease (CAD) (Ischemic Heart
Disease) - Overview 7
Pipeline
Products for Chronic Coronary Artery Disease (CAD) (Ischemic Heart
Disease) - Comparative Analysis 8
Chronic
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Therapeutics
under Development by Companies 9
Chronic
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline
Products Glance 10
Clinical
Stage Products 10
Early
Stage Products 11
Chronic
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Products
under Development by Companies 12
Chronic
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Companies
Involved in Therapeutics Development 13
Human
Stem Cells Institute 13
Lacer,
S.A. 14
Nuo
Therapeutics, Inc. 15
Chronic
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Therapeutics
Assessment 16
Assessment
by Monotherapy Products 16
Assessment
by Target 17
Assessment
by Mechanism of Action 18
Assessment
by Route of Administration 19
Assessment
by Molecule Type 21
For
Market Research Latest Reports Visit @
http://www.researchmoz.us/latest-report.html
About ResearchMoz
ResearchMoz is the one stop online
destination to find and buy market research reports & Industry
Analysis. We fulfill all your research needs spanning across industry
verticals with our huge collection of market research reports. We
provide our services to all sizes of organizations and across all
industry verticals and markets. Our Research Coordinators have
in-depth knowledge of reports as well as publishers and will assist
you in making an informed decision by giving you unbiased and deep
insights on which reports will satisfy your needs at the best price.
For More Information Kindly
Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Mr. Nachiket Ghumare,
Tel:
+1-518-621-2074
USA-Canada Toll Free: 866-997-4948
USA-Canada Toll Free: 866-997-4948
Website:
http://www.researchmoz.us/
